STAG2 is a major bladder tumor suppressor. This study analyzes how STAG2 loss-of-function affects genomic architecture and gene expression in bladder cancer cells, revealing distinctive distributions and interactions compared to STAG1. The findings link STAG2 inactivation to a shift from luminal to basal transcriptional programs, offering insights into bladder cancer progression.